Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Needle Free Injection Market: By Product, Source of Power, Type, Site of Delivery, Application, and End User and Region Forecast 2019-2030
Needle Free Injection Market size was valued at US$ 125 million in 2023 and is poised to grow at a CAGR of 17.2% from 2024-2030. Due to the increase in prevalence of various types of chronic diseases such as cancer, diabetes and so on, risk of exposure to communicable diseases due to needle stick injuries, and decrease in healthcare costs. Moreover, the advantage of painlessness, the wide range of applications with the needle-free injection, and the rise in R&D activities for the development of needle-free injections are the major factors that are driving the growth of the global market over the forecast timeframe.
This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global needle free injection products.
Study Period
2024-2030Base Year
2023CAGR
17.2%Largest Market
North-AmericaFastest Growing Market
Europe
Increase in the prevalence of cancer, diabetes, and infectious diseases is a key factor drive the global needle free injection market. According to World Health Organization 2018, approximately 9.6 Mn death occurred due to cancer around the globe and approximately 422 Mn people are suffering from diabetes all over the world. Moreover, the raise in funding for the R&D activities by public and private sectors and the wide range of applications and advantages are anticipated to propel the global needle free injection market over the forecast years.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 125 million |
Market CAGR |
17.2% |
By Type of Medication |
|
By Product |
|
By Application |
|
By End User |
|
By Region |
|
Download Free Sample Report
The needle free injection market size was valued at US$ 125 million in 2023. and is projected to grow at a CAGR of 17.2% from 2024 to 2030.
The needle-free injection market: Antares Pharma, (U.S.) Crossject needle-free injection systems ( France) DAntonio Consultants International Inc. (U.S.) European Pharma Group (Netherlands) Endo Pharmaceuticals Inc. (Ireland) INJEX Pharma GmBH. (Germany) Medical International Technology, Inc., (Canada) National Medical Products Inc., (Saudi Arabia) Mika Medical Co., (Korea) PenJet Corporation. (U.S.)
The needle-free injection market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Needle Free Injection Market Introduction |
2.1.Global Needle Free Injection Market - Taxonomy |
2.2.Global Needle Free Injection Market - Definitions |
2.2.1.Type of Medication |
2.2.2.Product |
2.2.3.Application |
2.2.4.Region |
3. Global Needle Free Injection Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Needle Free Injection Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Needle Free Injection Market By Type of Medication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Liquid-Based Needle Free Injectors |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Projectile/Depot-Based Needle-Free Injectors |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Powder-Based Needle Free Injectors |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Needle Free Injection Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Prefilled Needle-Free Injectors |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Fillable Needle-Free Injectors |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Needle Free Injection Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Vaccine Delivery |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Insulin Delivery |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Pain Management |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Other Applications |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Needle Free Injection Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Needle Free Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Type of Medication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Liquid-Based Needle Free Injectors |
9.1.2.Projectile/Depot-Based Needle-Free Injectors |
9.1.3.Powder-Based Needle Free Injectors |
9.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Prefilled Needle-Free Injectors |
9.2.2.Fillable Needle-Free Injectors |
9.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Vaccine Delivery |
9.3.2.Insulin Delivery |
9.3.3.Pain Management |
9.3.4.Other Applications |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Needle Free Injection Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Type of Medication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Liquid-Based Needle Free Injectors |
10.1.2.Projectile/Depot-Based Needle-Free Injectors |
10.1.3.Powder-Based Needle Free Injectors |
10.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Prefilled Needle-Free Injectors |
10.2.2.Fillable Needle-Free Injectors |
10.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Vaccine Delivery |
10.3.2.Insulin Delivery |
10.3.3.Pain Management |
10.3.4.Other Applications |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Needle Free Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Type of Medication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Liquid-Based Needle Free Injectors |
11.1.2.Projectile/Depot-Based Needle-Free Injectors |
11.1.3.Powder-Based Needle Free Injectors |
11.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Prefilled Needle-Free Injectors |
11.2.2.Fillable Needle-Free Injectors |
11.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Vaccine Delivery |
11.3.2.Insulin Delivery |
11.3.3.Pain Management |
11.3.4.Other Applications |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Needle Free Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Type of Medication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Liquid-Based Needle Free Injectors |
12.1.2.Projectile/Depot-Based Needle-Free Injectors |
12.1.3.Powder-Based Needle Free Injectors |
12.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Prefilled Needle-Free Injectors |
12.2.2.Fillable Needle-Free Injectors |
12.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Vaccine Delivery |
12.3.2.Insulin Delivery |
12.3.3.Pain Management |
12.3.4.Other Applications |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Needle Free Injection Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Type of Medication Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Liquid-Based Needle Free Injectors |
13.1.2.Projectile/Depot-Based Needle-Free Injectors |
13.1.3.Powder-Based Needle Free Injectors |
13.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Prefilled Needle-Free Injectors |
13.2.2.Fillable Needle-Free Injectors |
13.3. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Vaccine Delivery |
13.3.2.Insulin Delivery |
13.3.3.Pain Management |
13.3.4.Other Applications |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Antares Pharma, , (U.S.) |
14.2.2.Crossject needle-free injection systems ( France) |
14.2.3.DAntonio Consultants International Inc. (U.S.) |
14.2.4.European Pharma Group (Netherlands) |
14.2.5.Endo Pharmaceuticals Inc. (Ireland) |
14.2.6.INJEX Pharma GmBH. (Germany) |
14.2.7.Medical International Technology, Inc., (Canada) |
14.2.8.National Medical Products Inc., (Saudi Arabia) |
14.2.9.Mika Medical Co., (Korea) |
14.2.10.PenJet Corporation. (U.S.) |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players